“…[1][2][3] Endoscopic therapies for esophageal varices, such as endoscopic injection sclerotherapy (EIS) and endoscopic variceal ligation (EVL), have improved the overall management of variceal hemorrhage, [4][5][6][7][8] and we have demonstrated that EIS is effective in prolonging the survival period of patients complicated by liver cirrhosis with hepatocellular carcinoma (HCC). 9 Prophylactic endoscopic treatment for high-risk esophageal varices has been widely performed in Japan, 6,[10][11][12][13][14][15][16][17] although the efficacy of prophylactic endoscopic treatment for esophageal varices is still controversial in other countries, including Western countries. 18,19 The aim of this study was to evaluate whether the application of prophylactic EIS for esophageal varices for patients complicated by liver cirrhosis is more beneficial compared with the application of emergency EIS.…”